COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis

The current challenge worldwide is the administration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. Even if rarely, severe vascular adverse reactions temporally related to vaccine administration have induced diffidence in the population at large. In particular, resea...

Full description

Bibliographic Details
Main Authors: Cristoforo Pomara, Francesco Sessa, Marcello Ciaccio, Francesco Dieli, Massimiliano Esposito, Giovanni Maurizio Giammanco, Sebastiano Fabio Garozzo, Antonino Giarratano, Daniele Prati, Francesca Rappa, Monica Salerno, Claudio Tripodo, Pier Mannuccio Mannucci, Paolo Zamboni
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/6/955
id doaj-ba26aa2967be48c6bb0d55151363ec21
record_format Article
spelling doaj-ba26aa2967be48c6bb0d55151363ec212021-06-01T01:13:13ZengMDPI AGDiagnostics2075-44182021-05-011195595510.3390/diagnostics11060955COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility DiagnosisCristoforo Pomara0Francesco Sessa1Marcello Ciaccio2Francesco Dieli3Massimiliano Esposito4Giovanni Maurizio Giammanco5Sebastiano Fabio Garozzo6Antonino Giarratano7Daniele Prati8Francesca Rappa9Monica Salerno10Claudio Tripodo11Pier Mannuccio Mannucci12Paolo Zamboni13Department of Medical, Surgical and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95121 Catania, ItalyDepartment of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, ItalyClinical Molecular Medicine and Laboratory Medicine, Institute of Clinical Biochemistry, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, ItalyCentral Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, 90128 Palermo, ItalyDepartment of Medical, Surgical and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95121 Catania, ItalyDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Pro.M.I.S.E.), University of Palermo, 90128 Palermo, ItalyClinical Pathology Unit, Garibaldi Centro Hospital, ARNAS Garibaldi, 95121 Catania, ItalyDepartment of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, 90128 Palermo, ItalyFondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Transfusion Medicine and Hematology, 20162 Milan, ItalyDepartment of Biomedicine and Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, ItalyDepartment of Medical, Surgical and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95121 Catania, ItalyTumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine Palermo, 90128 Palermo, ItalyFondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20162 Milan, ItalyHub Center for Venous and Lymphatic Diseases Regione Emilia-Romagna, Sant’Anna University Hospital of Ferrara, 44124 Ferrara, ItalyThe current challenge worldwide is the administration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. Even if rarely, severe vascular adverse reactions temporally related to vaccine administration have induced diffidence in the population at large. In particular, researchers worldwide are focusing on the so-called “thrombosis and thrombocytopenia after COVID-19 vaccination”. This study aims to establish a practical workflow to define the relationship between adverse events following immunization (AEFI) and COVID-19 vaccination, following the basic framework of the World Health Organization (WHO). Post-mortem investigation plays a pivotal role to support this causality relationship when death occurs. To demonstrate the usefulness and feasibility of the proposed workflow, we applied it to two exemplificative cases of suspected AEFI following COVID-19 vaccination. Based on the proposed model, we took into consideration any possible causality relationship between COVID-19 vaccine administration and AEFI. This led us to conclude that vaccination with ChAdOx1 nCov-19 may cause the rare development of immune thrombocytopenia mediated by platelet-activating antibodies against platelet factor 4 (PF4), which clinically mimics heparin-induced autoimmune thrombocytopenia. We suggest the adoption of the proposed methodology in order to confirm or rule out a causal relationship between vaccination and the occurrence of AEFI.https://www.mdpi.com/2075-4418/11/6/955SARS-CoV-2COVID-19vaccineimmune thrombocytopeniadisseminated intravascular coagulationdeep vein thrombosis
collection DOAJ
language English
format Article
sources DOAJ
author Cristoforo Pomara
Francesco Sessa
Marcello Ciaccio
Francesco Dieli
Massimiliano Esposito
Giovanni Maurizio Giammanco
Sebastiano Fabio Garozzo
Antonino Giarratano
Daniele Prati
Francesca Rappa
Monica Salerno
Claudio Tripodo
Pier Mannuccio Mannucci
Paolo Zamboni
spellingShingle Cristoforo Pomara
Francesco Sessa
Marcello Ciaccio
Francesco Dieli
Massimiliano Esposito
Giovanni Maurizio Giammanco
Sebastiano Fabio Garozzo
Antonino Giarratano
Daniele Prati
Francesca Rappa
Monica Salerno
Claudio Tripodo
Pier Mannuccio Mannucci
Paolo Zamboni
COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
Diagnostics
SARS-CoV-2
COVID-19
vaccine
immune thrombocytopenia
disseminated intravascular coagulation
deep vein thrombosis
author_facet Cristoforo Pomara
Francesco Sessa
Marcello Ciaccio
Francesco Dieli
Massimiliano Esposito
Giovanni Maurizio Giammanco
Sebastiano Fabio Garozzo
Antonino Giarratano
Daniele Prati
Francesca Rappa
Monica Salerno
Claudio Tripodo
Pier Mannuccio Mannucci
Paolo Zamboni
author_sort Cristoforo Pomara
title COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
title_short COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
title_full COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
title_fullStr COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
title_full_unstemmed COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
title_sort covid-19 vaccine and death: causality algorithm according to the who eligibility diagnosis
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-05-01
description The current challenge worldwide is the administration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. Even if rarely, severe vascular adverse reactions temporally related to vaccine administration have induced diffidence in the population at large. In particular, researchers worldwide are focusing on the so-called “thrombosis and thrombocytopenia after COVID-19 vaccination”. This study aims to establish a practical workflow to define the relationship between adverse events following immunization (AEFI) and COVID-19 vaccination, following the basic framework of the World Health Organization (WHO). Post-mortem investigation plays a pivotal role to support this causality relationship when death occurs. To demonstrate the usefulness and feasibility of the proposed workflow, we applied it to two exemplificative cases of suspected AEFI following COVID-19 vaccination. Based on the proposed model, we took into consideration any possible causality relationship between COVID-19 vaccine administration and AEFI. This led us to conclude that vaccination with ChAdOx1 nCov-19 may cause the rare development of immune thrombocytopenia mediated by platelet-activating antibodies against platelet factor 4 (PF4), which clinically mimics heparin-induced autoimmune thrombocytopenia. We suggest the adoption of the proposed methodology in order to confirm or rule out a causal relationship between vaccination and the occurrence of AEFI.
topic SARS-CoV-2
COVID-19
vaccine
immune thrombocytopenia
disseminated intravascular coagulation
deep vein thrombosis
url https://www.mdpi.com/2075-4418/11/6/955
work_keys_str_mv AT cristoforopomara covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT francescosessa covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT marcellociaccio covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT francescodieli covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT massimilianoesposito covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT giovannimauriziogiammanco covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT sebastianofabiogarozzo covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT antoninogiarratano covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT danieleprati covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT francescarappa covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT monicasalerno covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT claudiotripodo covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT piermannucciomannucci covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
AT paolozamboni covid19vaccineanddeathcausalityalgorithmaccordingtothewhoeligibilitydiagnosis
_version_ 1721412905132359680